Cargando…
Cancer Metabolism as a Mechanism of Treatment Resistance and Potential Therapeutic Target in Hepatocellular Carcinoma
Various molecular targeted therapies and diagnostic modalities have been developed for the treatment of hepatocellular carcinoma (HCC); however, HCC still remains a difficult malignancy to cure. Recently, the focus has shifted to cancer metabolism for the diagnosis and treatment of various cancers,...
Autores principales: | Lee, Misu, Ko, Haeyong, Yun, Mijin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Yonsei University College of Medicine
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6240564/ https://www.ncbi.nlm.nih.gov/pubmed/30450847 http://dx.doi.org/10.3349/ymj.2018.59.10.1143 |
Ejemplares similares
-
The critical role of glucose deprivation in epithelial-mesenchymal transition in hepatocellular carcinoma under hypoxia
por: Jo, Hanhee, et al.
Publicado: (2020) -
Impact of Exogenous Treatment with Histidine on Hepatocellular Carcinoma Cells
por: Park, Yusun, et al.
Publicado: (2022) -
Regulation of Acetate Utilization by Monocarboxylate Transporter 1 (MCT1) in Hepatocellular Carcinoma (HCC)
por: Jeon, Jeong Yong, et al.
Publicado: (2018) -
Extracellular Citrate Treatment Induces HIF1α Degradation and Inhibits the Growth of Low-Glycolytic Hepatocellular Carcinoma under Hypoxia
por: Kim, Seon Yoo, et al.
Publicado: (2022) -
Modulation of SIRT3 expression through CDK4/6 enhances the anti-cancer effect of sorafenib in hepatocellular carcinoma cells
por: Jo, Hanhee, et al.
Publicado: (2020)